RODGERS JAMES D,SHEPARD STACEY,ARVANITIS ARGYRIOS G,WANG HAISHENG,STORACE LOUIS,FOLMER BEVERLY,SHAO LIXIN,ZHU WENYU,GLENN JOSEPH P
申请号:
IN4790/KOLNP/2011
公开号:
IN2011KN04790A
申请日:
2011.11.21
申请国别(地区):
IN
年份:
2012
代理人:
摘要:
The present invention relates to N-(hetero)aryl-pyrrolidine derivatives of Formula (I): which are JAK inhibitors, such as selective JAK1 inhibitors, useful in the treatment of JAK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer.